On July 1st, The Indian Council of Medical Research (ICMR) had publicly stated that it aims to launch a Coronavirus vaccine, which is being developed in partnership with the Hyderabad-based Bharat Biotech by August 15th.
According to sources, an internal communication from ICMR to Bharat Biotech had reiterated that this novel vaccine should be launched for mass consumption latest by 15th August 2020 after completion of all clinical trials. The sources had also specified that though BBIL is working expeditiously to meet the target, the final outcome shall depend on the cooperation of all clinical trial sites involved in this project.
In recent days a message had gone viral on social media stating that the vaccine against COVID-19 to be produced by Bharat Biotech has already received permission from the central government and will be available in the market from 15 August.In the meantime, PM Modi had directed officials to broadly evaluate the available technology options which can form the backbone of the national endeavour to vaccinate all in the most efficient and timely manner.
Bharat Biotech however had not commented anything on the communications from ICMR. In recent days a message has gone viral on social media stating that the vaccine against COVID-19 to be produced by Bharat Biotech has already received permission from the central government and will be available in the market from 15th August. The message is being shared with a letter from ICMR about fast-tracking the clinical trials of the vaccine. But ICMR is refuting this message saying that 15th August was just a tentative and not final deadline.
Following an outrage by the medical community on the possible lapses that can occur in the vaccine owing to its much fast tracked production cycle, ICMR has reiterated that they are adhering to all global norms as far as clinical and pre-clinical norms are concerned.